Earn CME/CE in your profession:

Continuing Education Activity

Mononucleosis classically presents with fever, lymphadenopathy, and tonsillar pharyngitis. The term infectious mononucleosis was first used in the 1920s to describe a group of students with a similar pharyngeal illness and blood laboratory findings of lymphocytosis and atypical mononuclear cells. It was only later that the Epstein-Barr virus (EBV) was established as the cause of mononucleosis after an exposed healthcare worker developed a positive heterophile test. This activity reviews the cause, pathophysiology, and presentation of mononucleosis and highlights the role of the interprofessional team in its management.


  • Describe the pathophysiology of mononucleosis.
  • Review the presentation of mononucleosis.
  • Summarize the treatment of mononucleosis.
  • Outline the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by mononucleosis.


Mononucleosis classically presents with fever, lymphadenopathy, and tonsillar pharyngitis. The term “infectious mononucleosis” was first used in the 1920s to describe a group of students with a similar pharyngeal illness and blood laboratory findings of lymphocytosis and atypical mononuclear cells. It was only later that Epstein-Barr virus (EBV) was established as the cause of mononucleosis after an exposed healthcare worker developed a positive heterophile test.[1][2]


The cause of mononucleosis is the Epstein-Barr virus (EBV). EBV is a type of herpesvirus spread by contact, typically with salivary secretions. The duration of oral shedding is not entirely clear, but high levels of shedding can continue for a median of 6 months after illness onset. Transmission is generally person-to-person, but EBV is not considered a highly contagious disease. [3]

Besides EBV other causes include:

  • CMV
  • Adenovirus
  • Hepatitis A
  • HIV
  • Toxoplasma
  • Rubella


It is estimated that up to 95% of adults in the world are eventually seropositive to EBV. Therefore, EBV is widely disseminated in all population groups. The traditional age group where peak incidence is noted, however, is in 15 to 24-year olds. Classically, the symptomatic infection is in adolescents, which is why laypersons may refer to the infection as the “kissing disease.” Mononucleosis is uncommon in adults:  approximately 2% of all pharyngeal disease in adults is attributable to this disease. Adults are generally not susceptible to clinical illness because of previous exposure. In the United States, clinically evident infection occurs at rates estimated at 30 times higher in whites than in blacks. One explanation for this disparity is that if acquired at a young (childhood) age, EBV is often subclinical. This would suggest earlier EBV exposures in blacks, and a higher frequency of asymptomatic infection as young children. [1][4]

After exposure, the EBV infects the epithelial cells of the salivary glands and the oropharynx. Lymphocytes residing in the tonsils get exposed to the virus and then enter the bloodstream. Lymphoid hyperplasia is common and may be seen as generalized lymphadenopathy, tonsillitis, and hepatosplenomegaly.

The infection of the B-lymphocytes results in the production of immunoglobulins (heterophile antibodies).


When EBV is introduced into the oropharynx, the virus begins the replication process. There is a predilection for infection of the B-cells of lymphoid tissue. Subsequently, the infection spreads through the lymphatic system. The body reacts by developing antibodies against the virus. In 90% or more of cases, heterophile antibodies are produced in response to the infection with EBV. EBV is a lifelong infection with periodic reactivation.  In poor immune response systems, there is a small risk of EBV-induced malignancy, such as Hodgkin lymphoma.[5][6]

History and Physical

Fever, sore throat, fatigue, and tender lymph nodes are classic findings on history-taking in infected individuals with mononucleosis. The incubation period for mononucleosis is long averaging 3-6 weeks and most patients do not recall the exposure.

The classical triad is fever, pharyngitis, and lymphadenopathy. Additional complaints include a headache, general malaise, and poor oral intake.  Unfortunately for some, fatigue can be persistent for months in select individuals. Lymphadenopathy is more common in the posterior cervical region. The pharyngitis is often heralded with tonsillar exudates. Petechial lesions on the palate occur infrequently. Also, splenomegaly is a key finding on physical in up to half of patients with active clinical mononucleosis. Identification is important in patients prone to future injury, e.g., active sports participants. Skin examination in some patients may infrequently reveal a nonspecific, generalized maculopapular rash. This is separate from the antibiotic-induced rash discussed below.


As always, initial evaluation should include airway assessment to determine that the airway is patent and there is no impending occlusion or compromise. In rare instances, abscess or edema can impede proper maintenance of the airway. Also, determination of hemodynamic stability is important to rule out concomitant splenic injury or rupture in the acute illness of mononucleosis. Laboratory evaluation most commonly will reveal lymphocytosis, with a lymphocyte differential often greater than 50%. Atypical lymphocytosis of greater than 10% can be seen on blood smear. A general leukocytosis and occasionally thrombocytopenia may also be appreciated. Imaging is generally not needed in the evaluation of mononucleosis. The monospot (or heterophile antibody) test for mononucleosis is the diagnostic test of choice and is nearly 100% specific for the disease. The sensitivity of this test is closer to 85%.  If the patient is early in the illness, the test may be falsely negative, and it should be repeated later during the course of the disease. If the diagnosis is unclear, the patient should also undergo evaluation for streptococcal infection by rapid antigen testing or throat culture.[7][8][9]

Treatment / Management

Treatment is generally supportive for mononucleosis. Antipyretics and anti-inflammatory medications help to treat fever, sore throat, and the general fatigue seen in this illness. Hydration, rest, and good nutritional intake should also be encouraged. Corticosteroids are not generally recommended in the routine treatment of mononucleosis because of concerns with immunosuppression; however, in cases of airway obstruction, corticosteroids (and possible otolaryngology consultation) are indicated along with appropriate airway management. In instances where antibiotics have been inappropriately administered in patients with mononucleosis, a generalized maculopapular rash may develop. Classically, this is after administration of amoxicillin but can be seen with other antibiotics as well. All athletes should avoid sports during the early course of the illness (approximately three weeks) because of the splenic enlargement was seen in approximately 50% of patients with mononucleosis and the associated risk of splenic rupture.[10][11]

Differential Diagnosis

Many other viral and some rickettsial illnesses have characteristics similar to EBV. The differential includes cytomegalovirus, human immunodeficiency virus (HIV), human herpesvirus type 6, hepatitis B, and tick-borne illnesses such as Lyme disease. Primary HIV may present with mucocutaneous ulcerations; furthermore, skin rash is frequently seen in primary HIV and is far less common in mononucleosis.


The majority of patients with EBV infection recover without sequelae and develop lifelong immunity to controlling the dormant virus. The acute phase of the illness resolves by the second week, but malaise symptoms may persist for months. In rare situations, malignancies have been linked with EBV infection, but additional study is needed to prove causation. Resumption of normal activity should be guided by the risk of splenic injury as well as other limitations that may be imposed by the fatigue that accompanies the illness.

Airway obstruction due to edema of the pharyngeal lymph nodes has also been reported. In addition, CNS complications include encephalitis, psychosis, cranial nerve palsies, peripheral neuritis, and Guillain barre syndrome.


  • Upper airway obstruction from massive lymphadenopathy
  • Splenic rupture
  • Autoimmune hemolytic anemia
  • Pancytopenia
  • Hemolytic uremic syndrome
  • Episcleritis, uveitis
  • Erythema multiforme

Pearls and Other Issues

The diagnostic test of choice for mononucleosis is the heterophile antibody (monospot) test. This can be occasionally falsely negative in early disease and require repeat testing later in the course of the illness.

The most important entity to exclude from the differential diagnosis is primary HIV infection.

Splenic rupture is a rare complication in mononucleosis but can be potentially life-threatening if not diagnosed in a timely fashion.  Consider it on the differential in the patient with classic mononucleosis, abdominal pain, and anemia. Airway obstruction is another rarely seen adverse outcome that requires immediate treatment and management. 

Enhancing Healthcare Team Outcomes

Once a patient has been diagnosed with infectious mononucleosis, the nurse practitioner and primary care provider should educate the patient on potential complications and the course of the illness. The patient should be told to avoid all physical activity for at least 4-6 weeks to minimize the risk of splenic rupture. The patient should be told about the signs and symptoms of splenic rupture and when to return to the hospital. All patients should be told about the need to follow up until the symptoms subside and permission to return to physical activity.  The nurse should educate the patient on supportive care, the need to remain hydrated, and assist in educating the patient and family on precautions to take to avoid the spread of the infection as well as when to return for further evaluation. Finally, all clinicians looking after patients with mononucleosis should be aware of the potential complications, and make the appropriate referral to the specialist when symptoms arise.[12][13] an interprofessional team approach to the evaluation and education of the patient will lead to the best outcomes. (Level V)


The majority of individuals who develop mononucleosis have an excellent outcome. The disorder is self-limited and recovery is common in 2-4 weeks. The rare patient may develop a splenic rupture but even these cases are now managed conservatively as long as the patient remains hemodynamically stable.[14][15] (Level V)

(Click Image to Enlarge)
Main symptoms of infectious mononucleosis
Main symptoms of infectious mononucleosis
Contributed by Wikimedia Commons,"Medical gallery of Mikael Häggström 2014" (Public Domain)

(Click Image to Enlarge)
Reactive Lymphocytes, Morphology, Infectious Mononucleosis, peripheral smear
Reactive Lymphocytes, Morphology, Infectious Mononucleosis, peripheral smear
Contributed by Ed uthman (CC by 2.0)

(Click Image to Enlarge)
<p>Follicular Conjunctivitis

Follicular Conjunctivitis. Inflammation is noted with viral infections like herpes zoster, Epstein-Barr virus infection, infectious mononucleosis, and chlamydial infections, as well as in reaction to topical medications and molluscum contagiosum. Follicular conjunctivitis has been described in patients with COVID-19. The inferior and superior tarsal conjunctiva and the fornices show gray-white elevated swellings about 0.5 to 1 mm in diameter and have a velvety appearance.

Contributed by Prof. BCK Patel MD, FRCS



Charles Graham


8/8/2023 12:17:57 AM

Nursing Version:

Mononucleosis (Nursing)



Smatti MK, Al-Sadeq DW, Ali NH, Pintus G, Abou-Saleh H, Nasrallah GK. Epstein-Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update. Frontiers in oncology. 2018:8():211. doi: 10.3389/fonc.2018.00211. Epub 2018 Jun 13     [PubMed PMID: 29951372]


Stemberger M, Jung C, Bogner JR. [Mononucleosis: a disease with three different etiologies]. MMW Fortschritte der Medizin. 2018 May:160(10):44-48. doi: 10.1007/s15006-018-0582-1. Epub     [PubMed PMID: 29855902]


Correia S, Bridges R, Wegner F, Venturini C, Palser A, Middeldorp JM, Cohen JI, Lorenzetti MA, Bassano I, White RE, Kellam P, Breuer J, Farrell PJ. Sequence Variation of Epstein-Barr Virus: Viral Types, Geography, Codon Usage, and Diseases. Journal of virology. 2018 Nov 15:92(22):. doi: 10.1128/JVI.01132-18. Epub 2018 Oct 29     [PubMed PMID: 30111570]


Downham C, Visser E, Vickers M, Counsell C. Season of infectious mononucleosis as a risk factor for multiple sclerosis: A UK primary care case-control study. Multiple sclerosis and related disorders. 2017 Oct:17():103-106. doi: 10.1016/j.msard.2017.07.009. Epub 2017 Jul 8     [PubMed PMID: 29055437]

Level 2 (mid-level) evidence


Burnard S, Lechner-Scott J, Scott RJ. EBV and MS: Major cause, minor contribution or red-herring? Multiple sclerosis and related disorders. 2017 Aug:16():24-30. doi: 10.1016/j.msard.2017.06.002. Epub 2017 Jun 10     [PubMed PMID: 28755681]


Womack J, Jimenez M. Common questions about infectious mononucleosis. American family physician. 2015 Mar 15:91(6):372-6     [PubMed PMID: 25822555]


Koester TM, Meece JK, Fritsche TR, Frost HM. Infectious Mononucleosis and Lyme Disease as Confounding Diagnoses: A Report of 2 Cases. Clinical medicine & research. 2018 Dec:16(3-4):66-68. doi: 10.3121/cmr.2018.1419. Epub 2018 Aug 30     [PubMed PMID: 30166498]

Level 3 (low-level) evidence


Kolesnik Y, Zharkova T, Rzhevskaya O, Kvaratskheliya T, Sorokina O. [CLINICAL AND IMMUNOLOGICAL CRITERIA FOR THE ADVERSE COURSE OF INFECTIOUS MONONUCLEOSIS IN CHILDREN]. Georgian medical news. 2018 May:(278):132-138     [PubMed PMID: 29905559]


Li Y, George A, Arnaout S, Wang JP, Abraham GM. Splenic Infarction: An Under-recognized Complication of Infectious Mononucleosis? Open forum infectious diseases. 2018 Mar:5(3):ofy041. doi: 10.1093/ofid/ofy041. Epub 2018 Feb 17     [PubMed PMID: 29577060]


Vogler K, Schmidt LS. [Clinical manifestations of Epstein-Barr virus infection in children and adolescents]. Ugeskrift for laeger. 2018 May 14:180(20):. pii: V09170644. Epub     [PubMed PMID: 29761777]


Dunmire SK, Verghese PS, Balfour HH Jr. Primary Epstein-Barr virus infection. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2018 May:102():84-92. doi: 10.1016/j.jcv.2018.03.001. Epub 2018 Mar 5     [PubMed PMID: 29525635]


Olympia RP. School Nurses on the Front Lines of Medicine: A Student With Fever and Sore Throat. NASN school nurse (Print). 2016 May:31(3):150-2. doi: 10.1177/1942602X16642252. Epub     [PubMed PMID: 27091630]


Grimes RM, Hardwicke RL, Grimes DE, DeGarmo DS. When to consider acute HIV infection in the differential diagnosis. The Nurse practitioner. 2016 Jan 16:41(1):. doi: 10.1097/01.NPR.0000475371.63182.b7. Epub     [PubMed PMID: 26678418]


Aslan N, Watkin LB, Gil A, Mishra R, Clark FG, Welsh RM, Ghersi D, Luzuriaga K, Selin LK. Severity of Acute Infectious Mononucleosis Correlates with Cross-Reactive Influenza CD8 T-Cell Receptor Repertoires. mBio. 2017 Dec 5:8(6):. doi: 10.1128/mBio.01841-17. Epub 2017 Dec 5     [PubMed PMID: 29208744]


De Paor M, O'Brien K, Fahey T, Smith SM. Antiviral agents for infectious mononucleosis (glandular fever). The Cochrane database of systematic reviews. 2016 Dec 8:12(12):CD011487. doi: 10.1002/14651858.CD011487.pub2. Epub 2016 Dec 8     [PubMed PMID: 27933614]

Level 1 (high-level) evidence